Published in Pharma Investments, Ventures and Law Weekly, December 10th, 2006
Upon closing of the purchase of the over-allotment shares, a total of 5,175,000 shares of common stock have been sold, resulting in gross proceeds of $59.5 million, before commissions and expenses, and net proceeds before expenses of $55.3 million. Cowen and Company, LLC acted as the sole book-running manager, CIBC World Markets Corp. acted as co-lead manager and JMP Securities LLC was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.